Literature DB >> 2546952

Expression and characterization of mutant forms of the type I regulatory subunit of cAMP-dependent protein kinase. The effect of defective cAMP binding on holoenzyme activation.

T A Woodford1, L A Correll, G S McKnight, J D Corbin.   

Abstract

The mouse wild type and four mutant regulatory type I (RI) subunits were expressed in Escherichia coli and subjected to kinetic analyses. The defective RI subunits had point mutations in either cAMP-binding site A (G200/E), site B (G324/D, R332/H), or in both binding sites. In addition, a truncated form of RI which lacked the entire cAMP-binding site B was generated. All of the mutant RI subunits which bound [3H]cAMP demonstrated more rapid rates of cAMP dissociation compared to the wild type RI subunit. Dissociation profiles showed only a single dissociation component, suggesting that a single nonmutated binding site was functional. The mutant RI subunits associated with purified native catalytic subunit to form chromatographically separable holoenzyme complexes in which catalytic activity was suppressed. Each of these holoenzymes could be activated but showed varying degrees of cAMP responsiveness with apparent Ka values ranging from 40 nM to greater than 5 microM. The extent to which the mutated cAMP-binding sites were defective was also shown by the resistance of the respective holoenzymes to activation by cAMP analogs selective for the mutated binding sites. Kinetic results support the conclusions that 1) Gly-200 of cAMP-binding site A and Gly-324 or Arg-332 of site B are essential to normal conformation and function, 2) activation of type I cAMP-dependent protein kinase requires that only one of the cAMP-binding sites be functional, 3) mutational inactivation of site B (slow exchange) has a much more drastic effect than that of site A on increasing the Ka of the holoenzyme for cAMP, as well as in altering the rate of cAMP dissociation from the remaining site of the free RI subunit. The strong dependence of one cAMP-binding site on the integrity of the other site suggests a tight association between the two sites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546952

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons.

Authors:  D G Howe; K D McCarthy
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

2.  Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors.

Authors:  Frédéric Preitner; Mark Ibberson; Isobel Franklin; Christophe Binnert; Mario Pende; Asllan Gjinovci; Tanya Hansotia; Daniel J Drucker; Claes Wollheim; Rémy Burcelin; Bernard Thorens
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

3.  Protein kinase A-dependent inhibition of alkaline phosphatase release by SaOS-2 human osteoblastic cells: studies in new mutant cell lines that express a cyclic AMP-resistant phenotype.

Authors:  S Fukayama; A K Kearns; R M Skurat; A H Tashjian; F R Bringhurst
Journal:  Cell Regul       Date:  1991-11

4.  Selective expression of a dominant-negative type Iα PKA regulatory subunit in striatal medium spiny neurons impairs gene expression and leads to reduced feeding and locomotor activity.

Authors:  Linghai Yang; Merle L Gilbert; Ruimao Zheng; G Stanley McKnight
Journal:  J Neurosci       Date:  2014-04-02       Impact factor: 6.167

5.  Expression of a dominant negative PKA mutation in the kidney elicits a diabetes insipidus phenotype.

Authors:  Merle L Gilbert; Linghai Yang; Thomas Su; G Stanley McKnight
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

6.  Crosstalk between PKA and PKG controls pH-dependent host cell egress of Toxoplasma gondii.

Authors:  Yonggen Jia; Jean-Baptiste Marq; Hugo Bisio; Damien Jacot; Christina Mueller; Lu Yu; Jyoti Choudhary; Mathieu Brochet; Dominique Soldati-Favre
Journal:  EMBO J       Date:  2017-10-13       Impact factor: 11.598

7.  Type II regulatory subunits are not required for the anchoring-dependent modulation of Ca2+ channel activity by cAMP-dependent protein kinase.

Authors:  K A Burton; B D Johnson; Z E Hausken; R E Westenbroek; R L Idzerda; T Scheuer; J D Scott; W A Catterall; G S McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

8.  Transfection-mediated expression of a dominant cAMP-resistant phenotype in the opossum kidney (OK) cell line prevents parathyroid hormone-induced inhibition of Na-phosphate cotransport. A protein kinase-A-mediated event.

Authors:  J H Segal; A S Pollock
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

9.  A constitutively active holoenzyme form of the cAMP-dependent protein kinase.

Authors:  Y H Wang; J D Scott; G S McKnight; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

10.  Cloning and characterization of a cdc25 phosphatase from mouse lymphocytes.

Authors:  J L Nargi; T A Woodford-Thomas
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.